Ll. Bellush et al., Protection against diabetes-induced nephropathy in growth hormone receptor/binding protein gene-disrupted mice, ENDOCRINOL, 141(1), 2000, pp. 163-168
To further investigate the role of GH in diabetic nephropathy, experimental
diabetes was induced with streptozotocin (STZ) in mice in which the GH rec
eptor/binding protein gene was disrupted. Body weight, blood glucose, and r
enal histology and morphometry were studied 10 weeks after diabetes inducti
on in wild-type (+/+) mice and in mice heterozygous (+/-) and homozygous (-
/-) for the disruption. Equivalent levels of hyperglycemia developed in all
diabetic groups. Normal weight gain was absent in +/+ and +/- diabetic gro
ups, and -/- diabetics lost weight during the study. Diabetic +/+ and +/- g
roups both showed evidence of glomerulosclerosis, increases in glomerular v
olume, and increases in the ratio of mesangial area to total glomerular are
a, whereas diabetic -/- mice showed none of these pathological changes. The
se results extend our previous findings of protection against diabetes-asso
ciated kidney damage in transgenic mice expressing a GH antagonist. Taken t
ogether, the results argue for an important role of GH in the development o
f diabetes induced end-organ damage.